Past Events

As data-driven innovation accelerates, healthcare stakeholders still struggle with a central question: How do we quantify the value of the data we hold? Even with unprecedented volumes of clinical and operational data, valuation methods remain fragmented and inconsistent. Providers, entrepreneurs and investors often approach data with very different priorities and expectations. Persistent challenges include gaps between perceived and realizable data value, difficulty comparing heterogeneous datasets, and increasing legal and regulatory constraints.

This session will examine how hospitals, digital health innovators, medtech companies and investors are defining and benchmarking data value in real-world transactions. The panel will also explore recommendations for strong data-sharing agreements and how expectations for rigorous, auditable valuation models are evolving.

RSVP here. 

Panelists include:

• Roger Cohen, Partner, Goodwin Procter (Moderator)
• Greg Banker, Partner, Vensana Capital
• Chris David, Founder & Managing Partner, HealthValue Group
• Natasha Hunerlach, Partner, EY/Parthenon
• Stefan Vilsmeier, Founder, President & CEO, Brainlab

*This program is being organized by BioVenture eLab of Weill Cornell Medicine Enterprise Innovation with Wendy Diller, founder of LifeScInnovation and author of “Data is the New Gold: Quantifying Its Value To Medtech Presents Challenges,” published in the October 2025 issue of Medtech Strategist.

Could your innovative research change the world? Participate in a free, month-long course to receive expert guidance as you evaluate the market potential of your deep technology innovation. You’ll gain a deeper understanding of your industry and learn valuable professional skills in the process. These virtual and conference-based courses are led by the Interior Northeast I-Corps Hub. 

The following conference course begins online and features funded customer discovery travel to an industry-specific event: 

• February 13 – March 18: Open to researchers developing digital health innovations. Features travel to Las Vegas, NV for the HIMSS Global Health Conference & Exhibition. Hosted in partnership with University at Buffalo & University of Vermont. Apply by January 21. 

The following virtual courses are open to innovators in all STEM fields: 

• January 16 – February 19: Hosted in partnership with Binghamton University. Apply by December 10. 
• February 2 – March 4: Hosted in partnership with University of Pittsburgh. Apply by January 7. 
• February 23 – March 25: Open to startup/incubator teams. Hosted in partnership with Syracuse University. Apply by January 28. 
• March 9 – April 8: Hosted in partnership with Dartmouth College. Apply by February 11. 

Applications will be reviewed on a rolling basis. Apply now! Please contact icorps@cornell.edu for any questions. 

Are you a researcher looking to make an impact through innovation? Explore technology commercialization through Introduction to Entrepreneurship for Ph.D.s and Postdocs, a program that empowers researchers to bring innovations to market and overcome the challenges of leading a technology-based business. 

This program combines a proven entrepreneurship curriculum with a focus on leadership development and empowerment. Content will be delivered at two full-day, on-campus (in Ithaca) weekend workshops in Spring 2026: 

• Workshop 1 in January will focus on fostering entrepreneurial skills and community-building with the cohort 
• Workshop 2 in February will focus on fundraising, operations, and next steps 

Participants will finish the program equipped to take the next steps in their entrepreneurship journeys. All students at Cornell conducting research at the graduate level and higher are welcome to apply by November 20, 2025. 

Contact the program team by emailing crea@cornell.edu. 

The Dean’s Office and Enterprise Innovation invite you to an afternoon filled with insightful discussions on biomedical innovation and entrepreneurship and a celebration of Weill Cornell’s innovator-entrepreneurs.

This symposium features:

• A fireside chat with Dean Robert A. Harrington and Barry Kappel, Ph.D. ’06, M.B.A., Founder, President, CEO & Director of Sapience Therapeutics
• Faculty and industry presentations and panel on innovation and aging
• Presentation on developing a novel DBS treatment for traumatic brain injury by Nicholas Schiff, M.D. ’92, Professor of Neuroscience

• One-on-one office hours with business development and licensing experts

• Introduction of EI Catalyst Fund

• A networking reception

RSVP here.